Green and Hill Industries, Inc Share Price Other OTC
Equities
GHIL
US39260U1060
Pharmaceuticals
Sales 2013 | - | Sales 2014 | 0 0.01 | Capitalization | 103 8.21K |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | - 0 | EV / Sales 2013 * | - |
Net cash position 2013 * | - 0 | Net cash position 2014 * | - 0 | EV / Sales 2014 * | - |
P/E ratio 2013 * |
-
| P/E ratio 2014 * |
-
| Employees | - |
Yield 2013 * |
-
| Yield 2014 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 16/03/14 |
Patrick Smyth
PSD | President | - | 16/03/14 |
Lorne Green
SEC | Corporate Secretary | - | 11/01/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Smyth
PSD | President | - | 16/03/14 |
Lorne Green
SEC | Corporate Secretary | - | 11/01/13 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 16/03/14 |
1st Jan change | Capi. | |
---|---|---|
+43.25% | 6.3B | |
-15.08% | 4.53B | |
-6.70% | 3.29B | |
+5.47% | 3.2B | |
+0.76% | 2.63B | |
+47.75% | 1.97B | |
-5.08% | 1.74B | |
+2.05% | 1.69B | |
-7.08% | 1.64B |